PCAT1 and non-small cell lung carcinoma: In NSCLC, elevated levels of prostate cancer-associated transcript 1 (PCAT1) create an immunosuppressive milieu and enhance radioresistance by impeding T-cell activation via the suppression of the cGAS/STING signaling pathway [78].